| Literature DB >> 31833428 |
Jeffrey I Cohen1, Keiji Iwatsuki2, Young-Hyeh Ko3, Hiroshi Kimura4, Irini Manoli5, Koichi Ohshima6, Stefania Pittaluga7, Leticia Quintanilla-Martinez8, Elaine S Jaffe7.
Abstract
Epstein-Barr virus (EBV) normally infects B cells, but in some persons the virus infects T or NK cells. Infection of B cells can result in infectious mononucleosis, and the virus is associated with several B cell malignancies including Hodgkin lymphoma, Burkitt lymphoma, and diffuse large B cell lymphoma. Infection of T or NK cells with EBV is associated with extranodal NK/T cell lymphoma, aggressive NK-cell leukemia, systemic EBV-associated T-cell lymphoma, and chronic active EBV disease, which in some cases can include hydroa vacciniforme-like lymphoproliferative disease and severe mosquito bite allergy. While NK and T cell lymphoproliferative disease is more common in Asia and Latin America, increasing numbers of cases are being reported from the United States and Europe. This review focuses on classification, clinical findings, pathogenesis, and recent genetic advances in NK and T cell lymphoproliferative diseases associated with EBV.Entities:
Keywords: Aggressive NK-cell leukemia; chronic active EBV disease; extranodal NK/T cell lymphoma; hydroa vacciniforme-like lymphoproliferative disease; severe mosquito bite allergy; systemic EBV-positive T-cell lymphoma of childhood
Mesh：
Year: 2019 PMID： 31833428 DOI： 10.1080/10428194.2019.1699080
Source DB: PubMed Journal: Leuk Lymphoma ISSN： 1026-8022